Translational medicine as a permanent glue and force of clinical medicine and public health: perspectives (1) from 2012 Sino-American symposium on clinical and translational medicine
1 Department of Pulmonary Medicine, Fudan University School of Medicine, Zhongshan Hospital, Shanghai, China
2 Biomedical Research Center, Fudan University School of Medicine, Zhongshan Hospital, Shanghai, China
3 Center of Academicians, Shanghai, China
Clinical and Translational Medicine 2012, 1:21 doi:10.1186/2001-1326-1-21Published: 5 October 2012
Health systems globally face challenges and opportunities in balancing quality, access, and cost, where clinical and translational medicine (CTM) should play more important and powerful roles in the identification, development and validation of solutions and strategies. Strategic collaboration can gather global strengths and resources and improve health systems, care delivery, regulations and policies. CTM-driven innovation and development has the potential to achieve step-change improvements across three dimensions. Thus, we have the reasons to believe that CTM will play even more roles in the development of new diagnostics, therapies, healthcare, and policies and SAS-CTM will become more and more important platform to obtain the latest development in CTM internationally and explore new opportunities in the international collaborations.